OtherDPO

FDA 21 CFR Part 11 for DPOs

What does FDA 21 CFR Part 11 require of a DPO?

21 CFR Part 11 (62 FR 13430 March 20 1997) establishes the criteria under which the FDA considers electronic records + electronic signatures to be trustworthy + reliable + equivalent to paper records + handwritten signatures. Under FDA 21 CFR Part 11, which defines 13 controls, a DPO's work is deciding which controls you own outright, which you share and which belong to another team, then holding the evidence for the first group.

Which FDA 21 CFR Part 11 controls land on the DPO

Data Protection Officers oversee privacy compliance, manage data subject rights requests, conduct privacy impact assessments, and serve as the point of contact with data protection authorities. The role is mandatory under GDPR for many organisations.

FDA 21 CFR Part 11 defines 13 controls across 7 domains that directly affect the DPO role. Understanding which controls fall within your ownership, which are shared, and which are owned by other teams is the foundation of effective compliance management.

What a DPO is accountable for under FDA 21 CFR Part 11

Advising the organisation on data protection obligations and best practices

Managing data subject access requests (DSARs) and privacy complaints

Conducting data protection impact assessments (DPIAs) for new processing activities

Maintaining records of processing activities and data flow maps

Serving as the liaison with data protection supervisory authorities

Where DPOs lose time on FDA 21 CFR Part 11

These are the most common obstacles DPOs face when managing FDA 21 CFR Part 11 compliance, and how to address them:

Challenge 1

Maintaining visibility over all personal data processing across the organisation

Challenge 2

Managing cross-border data transfer compliance (SCCs, adequacy decisions)

Challenge 3

Keeping privacy notices and consent mechanisms current across all channels

Challenge 4

Responding to DSARs within regulatory timeframes at scale

Challenge 5

Assessing privacy implications of AI and automated decision-making systems

A working order for a DPO starting on FDA 21 CFR Part 11

1. Readiness Assessment

Take a 5-minute readiness assessment to identify your organisation's current gap profile against FDA 21 CFR Part 11. Get a prioritised action plan tailored to your specific situation.

2. Cross-Framework Mapping

Use our platform to map FDA 21 CFR Part 11 controls against other frameworks you already comply with. FDA 21 CFR Part 11 maps to 86 other frameworks in our database.

3. Build Your Toolkit

Equip yourself with FDA 21 CFR Part 11 toolkits, self-assessments, and implementation guides from our store. Resources designed specifically for DPOs managing compliance programmes.

4. Continuous Monitoring

Establish ongoing compliance monitoring using our platform's gap analysis tools. Track your maturity over time and demonstrate progress to stakeholders.

FDA 21 CFR Part 11 in your sector

FDA 21 CFR Part 11 for Healthcare→FDA 21 CFR Part 11 for Financial Services→FDA 21 CFR Part 11 for Technology→FDA 21 CFR Part 11 for Government→FDA 21 CFR Part 11 for Manufacturing→FDA 21 CFR Part 11 for Energy→FDA 21 CFR Part 11 for Retail→FDA 21 CFR Part 11 for Education→

Who else owns part of FDA 21 CFR Part 11

FDA 21 CFR Part 11 for CISOsView guide →FDA 21 CFR Part 11 for Compliance OfficersView guide →FDA 21 CFR Part 11 for Risk ManagersView guide →FDA 21 CFR Part 11 for IT DirectorsView guide →FDA 21 CFR Part 11 for AuditorsView guide →

Questions DPOs ask about FDA 21 CFR Part 11

What does a DPO need to know about FDA 21 CFR Part 11?

As a DPO, your key responsibilities under FDA 21 CFR Part 11 include advising the organisation on data protection obligations and best practices and managing data subject access requests (dsars) and privacy complaints. The framework contains 13 controls that fall within your area of responsibility. Understanding which controls you own versus which are shared with other teams is critical for effective implementation.

How does FDA 21 CFR Part 11 affect the DPO role?

FDA 21 CFR Part 11 directly impacts DPOs through advising the organisation on data protection obligations and best practices, managing data subject access requests (dsars) and privacy complaints, conducting data protection impact assessments (dpias) for new processing activities. The framework provides structure that helps DPOs demonstrate due diligence and report compliance status to stakeholders.

What are the biggest FDA 21 CFR Part 11 challenges for DPOs?

Common challenges include maintaining visibility over all personal data processing across the organisation; managing cross-border data transfer compliance (sccs, adequacy decisions); keeping privacy notices and consent mechanisms current across all channels. Using cross-framework mapping tools and automated evidence collection can significantly reduce these pain points.

How should a DPO prepare for a FDA 21 CFR Part 11 audit?

Start by conducting a readiness assessment to identify gaps. Then focus on conducting data protection impact assessments (dpias) for new processing activities and maintaining records of processing activities and data flow maps. Maintain a current evidence repository and ensure all control owners have documented their processes. Our readiness reports provide a prioritised action plan specific to your gap profile.

What tools help DPOs manage FDA 21 CFR Part 11 compliance?

Effective FDA 21 CFR Part 11 compliance management requires tools for gap analysis, control mapping, evidence collection, and reporting. Our compliance platform provides AI-powered gap analysis across 1,120 frameworks with 315K+ verified control-to-control mappings, helping DPOs identify overlapping requirements and reduce duplicate compliance effort.

DPO: How ready is your organisation for FDA 21 CFR Part 11?

Answer 25 questions and get a professional readiness report with gap analysis, maturity scores, and prioritised action items. Results in 5 minutes.

Browse Toolkits & Resources

Written and maintained by Gerard Blokdyk, The Art of Service.Last updated 17 June 2026.